MediWound Ltd.
MDWD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 8.2% | -29.5% | 11.5% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 8.8% | 15.8% | 46.5% | 34.2% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -139.1% | -26.2% | -68.3% | -51% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -149.5% | -35.9% | -74% | -57% |
| EPS Diluted | -3.03 | -0.75 | -3.93 | -3.48 |
| % Growth | -304% | 80.9% | -12.9% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |